Medirom Healthcare Technologies Stock Buy Hold or Sell Recommendation
| MRM Stock | USD 0.95 0.02 2.15% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Medirom Healthcare Technologies is 'Strong Sell'. The recommendation algorithm takes into account all of Medirom Healthcare's available fundamental, technical, and predictive indicators you will find on this site.
Check out Medirom Healthcare Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Medirom and provide practical buy, sell, or hold advice based on investors' constraints. Medirom Healthcare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Medirom |
Execute Medirom Healthcare Buy or Sell Advice
The Medirom recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Medirom Healthcare Technologies. Macroaxis does not own or have any residual interests in Medirom Healthcare Technologies or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Medirom Healthcare's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Medirom Healthcare Trading Alerts and Improvement Suggestions
| Medirom Healthcare generated a negative expected return over the last 90 days | |
| Medirom Healthcare has high historical volatility and very poor performance | |
| Medirom Healthcare has some characteristics of a very speculative penny stock | |
| Medirom Healthcare has high likelihood to experience some financial distress in the next 2 years | |
| Medirom Healthcare Technologies has 3.65 B in debt. Medirom Healthcare has a current ratio of 0.35, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Medirom to invest in growth at high rates of return. | |
| Medirom Healthcare Technologies has about 354.95 M in cash with (631.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 72.7, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 40.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: Completion of Offering and Increase in Registered Capital |
Medirom Healthcare Returns Distribution Density
The distribution of Medirom Healthcare's historical returns is an attempt to chart the uncertainty of Medirom Healthcare's future price movements. The chart of the probability distribution of Medirom Healthcare daily returns describes the distribution of returns around its average expected value. We use Medirom Healthcare Technologies price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Medirom Healthcare returns is essential to provide solid investment advice for Medirom Healthcare.
| Mean Return | -1.8 | Value At Risk | -13.61 | Potential Upside | 10.33 | Standard Deviation | 8.26 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Medirom Healthcare historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Medirom Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Medirom Healthcare, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading Medirom Healthcare Technologies back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
| Shares | Ubs Group Ag | 2024-09-30 | 18 K | Virtu Financial Llc | 2024-09-30 | 10.9 K | Bank Of America Corp | 2024-09-30 | 25.0 |
Medirom Healthcare Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (2.4M) | (2.4M) | (95.4M) | (25.9M) | (23.3M) | (24.4M) | |
| Investments | 36.3M | (72.9M) | 580.4M | (328.6M) | (377.9M) | (359.0M) | |
| Change In Cash | 926.1M | (1.1B) | 234.8M | (499.1M) | (449.2M) | (426.7M) | |
| Free Cash Flow | (440.0M) | (671.0M) | (806.4M) | (767.6M) | (690.8M) | (725.4M) | |
| Depreciation | 62.3M | 126.2M | 184.1M | 252.6M | 290.5M | 305.0M | |
| Other Non Cash Items | (156.7M) | (442.3M) | (968.8M) | (1.4B) | (1.3B) | (1.2B) | |
| Capital Expenditures | 73.6M | 113.8M | 120.7M | 135.8M | 156.2M | 94.1M | |
| Net Income | (539.2M) | (990.7M) | 149.0M | 115.0M | 132.3M | 138.9M | |
| End Period Cash Flow | 1.4B | 370.6M | 605.5M | 106.3M | 95.7M | 90.9M |
Medirom Healthcare Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Medirom Healthcare or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Medirom Healthcare's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Medirom stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.81 | |
β | Beta against Dow Jones | 0.25 | |
σ | Overall volatility | 8.43 | |
Ir | Information ratio | -0.22 |
Medirom Healthcare Volatility Alert
Medirom Healthcare Technologies is displaying above-average volatility over the selected time horizon. Medirom Healthcare Technologies is a potential penny stock. Although Medirom Healthcare may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Medirom Healthcare Technologies. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Medirom instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Medirom Healthcare Fundamentals Vs Peers
Comparing Medirom Healthcare's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Medirom Healthcare's direct or indirect competition across all of the common fundamentals between Medirom Healthcare and the related equities. This way, we can detect undervalued stocks with similar characteristics as Medirom Healthcare or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Medirom Healthcare's fundamental indicators could also be used in its relative valuation, which is a method of valuing Medirom Healthcare by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Medirom Healthcare to competition |
| Fundamentals | Medirom Healthcare | Peer Average |
| Return On Equity | 1.47 | -0.31 |
| Return On Asset | -0.036 | -0.14 |
| Profit Margin | 0.02 % | (1.27) % |
| Operating Margin | (0.02) % | (5.51) % |
| Current Valuation | 29.3 M | 16.62 B |
| Shares Outstanding | 7.9 M | 571.82 M |
| Shares Owned By Insiders | 40.37 % | 10.09 % |
| Number Of Shares Shorted | 59.24 K | 4.71 M |
| Price To Book | 13.24 X | 9.51 X |
| Price To Sales | 0 X | 11.42 X |
| Revenue | 6.83 B | 9.43 B |
| Gross Profit | 1.57 B | 27.38 B |
| EBITDA | 310.08 M | 3.9 B |
| Net Income | 115.05 M | 570.98 M |
| Cash And Equivalents | 354.95 M | 2.7 B |
| Cash Per Share | 72.70 X | 5.01 X |
| Total Debt | 3.65 B | 5.32 B |
| Current Ratio | 0.36 X | 2.16 X |
| Book Value Per Share | 43.19 X | 1.93 K |
| Cash Flow From Operations | (631.74 M) | 971.22 M |
| Short Ratio | 0.71 X | 4.00 X |
| Earnings Per Share | (0.15) X | 3.12 X |
| Number Of Employees | 390 | 18.84 K |
| Beta | 0.009 | -0.15 |
| Market Capitalization | 7.33 M | 19.03 B |
| Total Asset | 6.85 B | 29.47 B |
| Retained Earnings | 80.28 M | 9.33 B |
| Working Capital | (1.8 B) | 1.48 B |
| Net Asset | 6.85 B |
Note: Disposition of 2500 shares by Cohen Edward H of Medirom Healthcare at 11.18 subject to Rule 16b-3 [view details]
Medirom Healthcare Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Medirom . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Medirom Healthcare Buy or Sell Advice
When is the right time to buy or sell Medirom Healthcare Technologies? Buying financial instruments such as Medirom Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Medirom Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Global Macro ETFs Thematic Idea Now
Global Macro ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Global Macro ETFs theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Global Macro ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Medirom Healthcare Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.582 | Earnings Share (0.15) | Revenue Per Share | Quarterly Revenue Growth (0.06) | Return On Assets |
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.